# Molecular Markers in Predicting Lung Cancer Development Using Tissue Samples From Healthy Participants

> **NCT00899457** · — · COMPLETED · sponsor: **Vanderbilt-Ingram Cancer Center** · enrollment: 37 (actual)

## Conditions studied

- Healthy, no Evidence of Disease
- Lung Cancer

## Interventions

- **GENETIC:** proteomic profiling
- **OTHER:** biologic sample preservation procedure
- **OTHER:** laboratory biomarker analysis
- **PROCEDURE:** bronchoscopy

## Key facts

- **NCT ID:** NCT00899457
- **Lead sponsor:** Vanderbilt-Ingram Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2014-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00899457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00899457, "Molecular Markers in Predicting Lung Cancer Development Using Tissue Samples From Healthy Participants". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00899457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*